Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2022)
Oruka Therapeutics' quarterly Interest Coverage Ratio came in at 850.67 in Q3 2022, up 48.08% quarter-over-quarter from 1638.5 in Q1 2022.
Oruka Therapeutics has reported Interest Coverage Ratio for 11 years, with the latest figure at 850.67 in Q3 2022.
- For the quarter ending Q3 2022, Interest Coverage Ratio changed N/A year-over-year to 850.67; the trailing twelve-month figure through Jun 2023 stood at 2623.0 (up 68.94% YoY), and the FY2022 full-year result was 2119.2, changed N/A from the prior year.
- Interest Coverage Ratio for Q3 2022 stood at 850.67, up from 1638.5 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 335.0 in Q1 2020, with the low at 1638.5 in Q1 2022.
- Average Interest Coverage Ratio over 4 years is 824.83, with a median of 831.0 recorded in 2018.
- Year-over-year, Interest Coverage Ratio jumped 74.14% in 2018 and tumbled 50.06% in 2019.
- Tracing ORKA's Interest Coverage Ratio over 4 years: stood at 831.0 in 2018, then slumped by 50.06% to 1247.0 in 2019, then rose by 20.21% to 995.0 in 2020, then climbed by 14.51% to 850.67 in 2022.
- The last three Interest Coverage Ratio figures came in at 850.67 (Q3 2022), 1638.5 (Q1 2022), and 995.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -850.67 |
| Mar 31, 2022 | -1,638.50 |
| Sep 30, 2020 | -995.00 |
| Jun 30, 2020 | -436.67 |
| Mar 31, 2020 | -335.00 |
| Sep 30, 2019 | -1,247.00 |
| Jun 30, 2019 | -502.67 |
| Mar 31, 2019 | -593.67 |
| Sep 30, 2018 | -831.00 |
| Jun 30, 2018 | -718.67 |
| Mar 31, 2018 | -924.33 |
| Sep 30, 2017 | -2,237.50 |
| Jun 30, 2017 | -2,779.50 |
| Mar 31, 2017 | -2,190.50 |
| Sep 30, 2015 | -2,817.00 |
| Jun 30, 2015 | -1,359.50 |
| Mar 31, 2015 | -2,744.00 |
| Sep 30, 2014 | -2,285.00 |
| Jun 30, 2014 | -2,406.00 |
| Mar 31, 2014 | -2,390.00 |
| Dec 31, 2013 | -2,947.00 |
| Jun 30, 2013 | -599.00 |
| Mar 31, 2013 | -1,070.00 |
| Sep 30, 2012 | -928.00 |
| Jun 30, 2012 | -572.50 |
| Mar 31, 2012 | -1,406.00 |
| Dec 31, 2011 | 408.50 |
| Sep 30, 2011 | -910.50 |
| Jun 30, 2011 | -852.00 |
| Mar 31, 2011 | -440.40 |
| Dec 31, 2010 | -2,352.00 |
| Sep 30, 2010 | -702.00 |
| Jun 30, 2010 | -1,134.50 |